SASalim Aminu

Salim Aminu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Salim Aminu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiology of Malaria in Bauchi North, Bauchi State Nigeria: Prevalence and Determinants of the Infection

    by Auwal Magaji, Zinat Mahmud, Adamu Yakubu, Rilwanu Salihu Maradun, Salim Aminu, Sabiu Aminu

    Study’s Excerpt: • The study assessed malaria prevalence and risk factors in Bauchi North, Bauchi State, Nigeria. • Microscopy detected the parasite, while structured questionnaires identified infection determinants. • Results showed a high malaria burden with variations by age and socioeconomic status. • Findings highlight the need for public health interventions targeting high-risk, vulnerable groups. • Findings can guide policymakers in malaria treatment, control, and prevention efforts. Full Abstract: Malaria remains a leading public health concern globally, particularly in sub-Saharan Africa, with Nigeria bearing a significant burden of the disease. This cross-sectional study aimed to assess malaria prevalence and associated risk factors among patients attending healthcare facilities in Bauchi North, Bauchi State, Nigeria. A total of 300 patients suspected of having malaria were enrolled, and blood samples were analyzed using microscopy of thick blood film stained with Giemsa’s stain. The presence of gametocytes, trophozoites, or schizonts, which stained dark blue, indicated positive results. Structured questionnaires were administered to collect demographic and risk factor data. The overall prevalence of malaria was 40%, with higher prevalence rates among females (27%) compared to males (13%) and among adults aged 25–64 years (24%). Rural residents (29.67%), individuals from low-income families (20.67%), and those exposed to poor housing and environmental conditions exhibited higher prevalence rates. The key risk factors assessed included residence of the patients, use of a net, and socioeconomic status, among which a history of fever within two weeks prior to the study (p = 0.006) was the only statistically significant risk factor associated with malaria at p < 0.05. Logistic regression analysis confirmed fever history as the primary predictor of malaria (COR = 0.438, 95% CI = 0.242–0.792). These findings highlighted the need for targeted malaria control interventions focusing on high-risk groups and environmental management. Strengthened public health campaigns are essential to improve awareness of the danger of malaria, its modes of transmission, infection agents, and preventive measures in underserved areas.


  • Open Access

    Urine Proteomics in Schistosoma haematobium-induced Bladder Cancer

    by Salim Aminu, Adejoke Obajuluwa Olukayode, Alhaji Madara Adamu, Pius Okiki Abimbola

    Schistosomiasis, or Bilharziasis, is a neglected tropical disease caused by Schistosoma parasites, which significantly impacts public health, particularly in Africa. Schistosoma haematobium, the primary species responsible for urogenital schistosomiasis (UGS), is associated with severe chronic conditions, including squamous cell carcinoma (SCC) of the bladder. This review explores the pathogenesis of UGS and its link to bladder cancer, highlighting the molecular mechanisms involved. The chronic inflammation caused by S. haematobium eggs leads to tissue damage, fibrosis, and granuloma formation, creating a pre-cancerous environment. Notably, the role of the p53 pathway in UGS-associated bladder cancer is emphasized, with mutations in the TP53 gene and overexpression of p53 contributing to genetic instability and malignant transformation. Additionally, the review discusses the presence of oestrogen-like metabolites in the urine of UGS patients, which are suspected to be involved in carcinogenesis through an oestrogen-DNA adduct-mediated pathway. Mass spectrometric analysis of urine samples from UGS patients revealed specific metabolites, including 8-oxodG, a marker of oxidative DNA damage, which could serve as potential biomarkers for early detection and progression of bladder cancer. The urine proteome profiling also identified distinct molecular pathways activated in UGS-related bladder cancer, including Th2-type immune responses, oxidative stress, and inflammation. These findings underscore the need for further research into the host-parasite interactions and the development of diagnostic biomarkers for schistosome-induced carcinogenesis. Understanding these mechanisms could enhance treatment strategies and improve prevention efforts for UGS-related bladder cancer, particularly in endemic regions where the disease burden remains high.